To assess the role of intratumoral heterogeneity between several biopsies within the tumor, KRAS mutation status was assessed in multiple biopsies obtained at the index rectoscopy as well as in tumor blocks from the surgically resected specimen. This evidence concerns the gene KRAS and neoplasm.